BAYER AKTIENGESELLSCHAFT «12345...» Page 5 out of 137 from 01/07/1988 to 14/05/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 13/05/2019 14:14 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK: Bayer to present new data at ASCO 2019 highlighting commitment to evolve cancer treatment paradigm Register number: 278168 29/04/2019 14:16 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK: U.S. - FDA accepts New Drug Application and grants Priority Review for darolutamide Register number: 277551 29/04/2019 08:01 BAYER AKTIENGESELLSCHAFT Announcements and resolutions of general shareholders meetings Bayer’s Supervisory Board unanimously stands behind Board of Management Register number: 277508 26/04/2019 10:38 BAYER AKTIENGESELLSCHAFT Information on P&L "We made great progress – both operationally and strategically” Register number: 277464 25/04/2019 09:26 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer AG: Public Information refered to Q1-2019 Register number: 277392 25/04/2019 08:03 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: strong operational start to the year Register number: 277377 25/04/2019 07:59 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Q1 2019 Analyst and Investor Briefing Register number: 277376 23/04/2019 11:08 BAYER AKTIENGESELLSCHAFT Announcements of public presentations and meetings Bayer: Save-the-Date for Crop Science Summer Technology Showcase on August 1 - 2, 2019 Register number: 277260 11/04/2019 11:04 BAYER AKTIENGESELLSCHAFT Announcements of public presentations and meetings Bayer: Q1 2019 Publication Schedule Register number: 277004 28/03/2019 08:34 BAYER AKTIENGESELLSCHAFT Legal disputes Bayer statement on jury’s decision in phase two of California glyphosate trial. Register number: 276497 Page 5 out of 137 «12345...»